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Antivirulence strategies aim to target pathogenicity factors while bypassing the pressure
on the bacterium to develop resistance. TheMgtCmembrane protein has been proposed
as an attractive target that is involved in the ability of several major bacterial pathogens,
including Pseudomonas aeruginosa, to survive inside macrophages. In liquid culture,
P. aeruginosaMgtC acts negatively on biofilm formation. However, a putative link between
these two functions of MgtC in P. aeruginosa has not been experimentally addressed. In
the present study, we first investigated the contribution of exopolysaccharides (EPS) in
the intramacrophage survival defect and biofilm increase ofmgtCmutant. Within infected
macrophages, expression of EPS genes psl and alg was increased in a P. aeruginosa
mgtC mutant strain comparatively to wild-type strain. However, the intramacrophage
survival defect ofmgtCmutant was not rescued upon introduction of psl or algmutation,
suggesting that MgtC intramacrophage role is unrelated to EPS production, whereas the
increased biofilm formation of mgtC mutant was partially suppressed by introduction
of psl mutation. We aimed to develop an antivirulence strategy targeting MgtC, by
taking advantage of a natural antagonistic peptide, MgtR. Heterologous expression
of mgtR in P. aeruginosa PAO1 was shown to reduce its ability to survive within
macrophages. We investigated for the first time the biological effect of a synthetic
MgtR peptide on P. aeruginosa. Exogenously added synthetic MgtR peptide lowered the
intramacrophage survival of wild-type P. aeruginosa PAO1, thusmimicking the phenotype
of an mgtC mutant as well as the effect of endogenously produced MgtR peptide.
In correlation with this finding, addition of MgtR peptide to bacterial culture strongly
reduced MgtC protein level, without reducing bacterial growth or viability, thus differing
from classical antimicrobial peptides. On the other hand, the addition of exogenous
MgtR peptide did not affect significantly biofilm formation, indicating an action toward
EPS-independent phenotype rather than EPS-related phenotype. Cumulatively, our
results show an antivirulence action of synthetic MgtR peptide, which may be more
potent against acute infection, and provide a proof of concept for further exploitation
of anti-Pseudomonas strategies.
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INTRODUCTION
The increasing understanding of bacterial pathogenesis has
revealed potential strategies to develop novel drugs against
infectious bacteria (Heras et al., 2015; Hauser et al., 2016;
Mühlen and Dersch, 2016; Dickey et al., 2017). Interference
with bacterial virulence is a promising alternative approach or
a complementary adjunct to traditional antimicrobial therapy.
This approach does not mediate direct bacterial killing, at
least in vitro, therefore it is thought to apply less selective
pressure for resistance and better preserve microbiota. The
MgtC membrane protein has been proposed as a suitable
target for antivirulence strategies because it is a virulence
factor conserved in several bacterial pathogens (Alix and Blanc-
Potard, 2007; Belon and Blanc-Potard, 2016). MgtC, which
was first described in Salmonella enterica serovar Typhimurium
(S. Typhimurium), is a critical factor for the intramacrophage
survival of various unrelated intracellular pathogens (Salmonella
spp.,Mycobacterium tuberculosis, Brucella suis and Burkholderia
cenocepacia), as well as so-called extracellular pathogens that
can transiently reside within cells (Yersinia pestis, Pseudomonas
aeruginosa) (Blanc-Potard and Groisman, 1997; Buchmeier et al.,
2000; Lavigne et al., 2005; Grabenstein et al., 2006; Maloney and
Valvano, 2006; Belon et al., 2015).
The environmental bacterium and opportunistic human
pathogen P. aeruginosa is responsible for a variety of acute
infections and is amajor cause ofmortality in chronically infected
cystic fibrosis (CF) patients. Due to the increasing number of
antibiotic resistant clinical isolates, P. aeruginosa has been listed
in the WHO top priority list for drug development (Tacconelli
et al., 2018). The chronic infection of P. aeruginosa and its
resistance to treatment is largely due to its ability to form
biofilms, which relies on the production of exopolysaccharides
(EPS), as reviewed by Klockgether and Tümmler (2017). Recent
studies have highlighted the role of intracellular stages during
P. aeruginosa infection, which may contribute to bacterial
dissemination and in vivo resistance to antibiotics (Brannon et al.,
2009; Buyck et al., 2013). In P. aeruginosa, mgtC expression
is induced inside macrophages, which is consistent with its
contribution to bacterial intramacrophage survival, and themgtC
mutant (in the PAO1 background) is attenuated in an acute
model of infection in zebrafish embryos (Belon et al., 2015;
Bernut et al., 2015). MgtC was also found to limit biofilm
formation and EPS production in magnesium deprived medium,
a condition known to activate mgtC transcription (Belon et al.,
2015). Interestingly, MgtC has been shown to repress cellulose
production in S. Typhimurium, which in turn promotes bacterial
replication within macrophages (Pontes et al., 2015). Cellulose
is not produced by P. aeruginosa, but these results suggested a
potential link between the production of P. aeruginosa EPS and
intramacrophage behavior (Belon et al., 2015; Bernut et al., 2015).
Three polysaccharides, namely Psl, Pel and alginate, compose
P. aeruginosa EPS (Wei and Ma, 2013), and contribute to the
formation of biofilms (Ghafoor et al., 2011). Psl has a major
contribution in biofilm formation, being required for adhesion
of bacteria, which is critical for biofilm initiation, as well as
maintenance of the biofilm structure. Pel is responsible for
pellicle formation on air-liquid interface and formation of solid
surface-associated biofilms. Pel could function together with
other EPS throughout biofilm development in P. aeruginosa
PAO1, although in a less important way as compared to Psl (Yang
et al., 2011). Alginate is the exopolysaccharide that is mainly
produced by P. aeruginosa clinical isolates from the lungs of
CF patients, where it plays important roles in structural stability
and protection of biofilms. However, it is not absolutely required
during the formation of non-mucoid biofilms in vitro, as shown
for PAO1 strain (Wozniak et al., 2003)
Of interest in the context of an antivirulence approach,
a natural peptide antagonistic to MgtC has been described.
This peptide, called MgtR, is a very small membrane protein
of 30 amino-acids (thus referred as peptide) identified in S.
Typhimurium, where it promotes the degradation of the MgtC
virulence factor by FtsH protease (Alix and Blanc-Potard, 2008;
Lee and Groisman, 2010). MgtR is part of a novel class of
regulatory molecules that can interact with membrane proteins
and can subsequently act on the stability of these membrane
proteins (Alix and Blanc-Potard, 2009; Lippa and Goulian,
2009; Wang et al., 2017). Overexpression of mgtR reduced
intramacrophage survival of a wild-type Salmonella strain, thus
indicating that MgtR can lower Salmonella virulence (Alix
and Blanc-Potard, 2008). MgtR has been shown to directly
interact with the Salmonella MgtC membrane protein (Alix and
Blanc-Potard, 2008). Moreover, the SalmonellaMgtR membrane
peptide can also interact with MgtC protein fromM. tuberculosis
and P. aeruginosa (Belon et al., 2015, 2016). M. tuberculosis and
all P. aeruginosa strains naturally lack mgtR gene, but ectopic
expression of Salmonella mgtR in mycobacteria and P. aeruginosa
mimicked the phenotypes reported for mgtC deletion mutants
(Belon et al., 2015, 2016). Thus, these findings show an
antivirulence action of MgtR upon endogenous production in
several bacterial pathogens.
In the present study, we addressed the contribution of
EPS to the phenotypes of P. aeruginosa mgtC mutant and
investigated further an antivirulence strategy targeting MgtC
on P. aeruginosa. We first investigated the contribution of
individual EPS components (alginate, Psl and Pel) to the
intramacrophage survival defect of P. aeruginosa mgtC mutant
as well as biofilm formation. Then, studies with synthetic peptide
added exogenously were carried out for the first time to further
evaluate the efficiency of an antivirulence strategy based onMgtR.
We investigated the biological effect of a synthetic MgtR peptide
toward P. aeruginosa ability to survive inside macrophages and
form biofilm.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Bacterial strains and plasmids are described in Table 1.
P. aeruginosa strains are in the PAO1 background. P. aeruginosa
was grown at 37◦C in Luria broth (LB). Growth in magnesium-
deprived medium was done in No-carbon essential (NCE)-
minimal medium (28mM KH2PO4, 28mM K2HPO4·3H2O,
16mM NaNH4HPO4·4H2O) supplemented with 0.1% casamino
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TABLE 1 | Bacterial strains and plasmids used in the study.
Name Description References
PAO1 Wild-type Laboratory collection
PAO1 1mgtC Belon et al., 2015
PAO1 1alg8 alg8 deletion mutant Periasamy et al., 2015
PAO1 1mgtC 1psl 1mgtC 1pslD This study
PAO1 1mgtC 1alg 1mgtC 1alg8 This study
pRK2013 Tra+, Mob+, ColE1, KmR Laboratory collection
pMF230 GFPmut2 Nivens et al., 2001
pKNG101 Suicide vector SmR; sacB+ Kaniga et al., 1991
pKNGpslD 1pslD deletion in pKNG101 This study
pSBC44 1mgtC deletion in pKNG101 Belon et al., 2015
acids, 38mM glycerol and 10µM MgSO4 as described earlier
(Rang et al., 2007). Plasmid pMF230 (constitutive GFP
expression, obtained from Addgene) was introduced in
P. aeruginosa by conjugation, using an E. coli strain containing
pRK2013. Recombinant bacteria were selected on Pseudomonas
isolation agar (PIA) containing carbenicillin at the concentration
of 300µg/ml. Construction of mgtC psl and mgtC alg double
mutant strains was done as described earlier (Belon et al., 2015)
by allelic exchange of the pslD gene in mgtC mutant using a
pKNGpslD suicide plasmid or allelic exchange of the mgtC gene
in the alg8mutant (harboring a deletion of alg operon) using the
pSBC44 suicide plasmid, respectively (Table 1).
Peptide Synthesis
MgtR peptide (MNRSPDKIIALIFLLISLLVLCLALWQIVF)
was synthesized by a solid-phase method using the Fmoc
methodology on an automated microwave peptide synthesizer
(Liberty-1, CEM, Orsay, France) as previously described (Belon
et al., 2016). H-Rink amide ChemMatrix resin (100 micromoles,
substitution 0.37 mmol/g, Longjumeau, France) was used. The
peptide was synthesized following a double-coupling step for
each amino acid (400 micromoles) activated with TBTU (500
micromoles). Additionally an acetylation step was applied at the
end of each amino-acid incorporation to prevent the formation
of incomplete peptides. At the end of the assembly, the
N-terminal Fmoc was kept on the peptide and the peptide/resin
was stored at 4◦C under inert atmosphere. When required,
peptide/resin was treated to remove the Fmoc group, rinsed and
dried under vacuum before the final deprotection procedure. The
peptide/resin was then treated with 10 ml/g of cleavage cocktail
(trifluoroacetic acid/triisopropylsilane/H2O/1,2-ethanedithiol
(94/1/2.5/2.5%: vol/vol) at room temperature for 90min. The
peptide was then precipitated with cold ether and centrifuged
before resuspension in acetonitrile/water (30/70: vol/vol),
freezing and freeze-drying. The final product was resuspended in
isopropanol/water (50%/50%: vol/vol) without any purification
and analyzed by MALDI-TOF mass spectrometry. The expected
mass is 3,456.39 and the measured one was 3,456.78 ([MH]+).
Circular dichroism spectra were recorded on a Jasco 810 (Japan)
dichrograph in quartz suprasil cells (Hellma) with an optical
path of 1mm using 40µM peptide in 30% isopropanol with and
without SDS 4%. For experimentations, peptide was resuspended
at a concentration of 3.2mM in DMSO/water (50%/50%: vol/vol)
and sonicated for 15min before use. Using the same procedure,
we also synthesized a scrambled peptide based on the amino-
acid sequence of MgtR (permutation of the original peptide,
ILFVADSLQMIPLCLRIWVALKINILFSVL).The measured mass
correlated with the expected one.
Infection of Macrophages and
Quantification of Intracellular Bacteria
J774 cells (J774A.1) were maintained at 37◦C in 5% CO2
in Dulbecco’s modified Eagle medium (DMEM) (Gibco)
supplemented with 10% fetal bovine serum (FBS) (Gibco). The
infection of J774 macrophages by P. aeruginosa was carried out
essentially as described previously (Belon et al., 2015). Mid-
log phase P. aeruginosa grown in LB broth was centrifuged
and resuspended in PBS to infect J774 macrophages (5×105
cells/well) at an MOI of 10. After 5min centrifugation of the
24-well culture plate for synchronization of infection, bacterial
phagocytosis was allowed to proceed for 25min. Cells were
washed three times with sterile PBS and fresh DMEM media
supplemented with 400µg/ml gentamicin was added, which was
retained throughout the infection. Macrophages were lysed after
20min (T0) or 2 h (T1) of gentamicin treatment, by using 0.1%
Triton X-100 and the number of viable bacteria was determined
by subsequent plating onto LB agar plates. The percentage of
survival was obtained by multiplying with 100 the ratio of the
bacterial colony forming units (CFU) at T1 to that of T0.
RNA Extraction and Quantitative
RT-PCR (qRT-PCR)
For bacterial RNA extraction from infected J774, 6.5 × 106
macrophages were seeded into a 100 cm2 tissue culture dish and
infected at an MOI of 10 as described above. One hour after
phagocytosis, cells were washed three times with PBS, lysed with
0.1% Triton X100 and pelleted by centrifugation at 13,000 rpm
for 10min at 15◦C. Bacteria were resuspended in 500 µl PBS
and the non-resuspended cellular debris were discarded. 900 µl
of RNA protect reagent (Qiagen) was added and incubated for
5min. The sample was centrifuged at 13,000 rpm for 10min.
Bacteria in the pellet were lysed with lysozyme and RNA was
prepared with RNEasy kit (Qiagen). Superscript III reverse
transcriptase (Invitrogen) was used for reverse transcription.
Controls without reverse transcriptase were done on each RNA
sample to rule out possible DNA contamination. Quantitative
real-time PCR (Q-RT-PCR) was performed using a Light Cycler
480 SYBR Green I Master mix in a 480 Light Cycler instrument
(Roche). PCR conditions were as follows: 3min denaturation
at 98◦C, 45 cycles of 98◦C for 5 s, 60◦C for 10 s, and 72◦C
for 10 s. The sequences of primers used for RT-PCR are listed
in Supplemental Table 1.
LDH Assay
The cytotoxicity of synthetic peptide was assessed by release of
lactate dehydrogenase (LDH) using the Pierce LDH cytotoxicity
assay kit (Thermo Scientific). Macrophages were seeded in a 96
well plate and treated with peptide (120µM) for 18 h. The assay
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was performed on 50 µl of the culture supernatant according
to manufacturer’s instructions. The percentage of LDH release
was first normalized to that of the untreated control and then
calculated relatively to that of untreated cells lysed with Triton
X-100, which was set at 100% LDH release.
Biofilm Formation
Biofilm formation in LB medium was carried out in 96-well
plate. Overnight culture of PAO1, grown in LB, was diluted 1:100
in LB and 200 µl was aliquoted in 96-well plate in triplicates.
Peptide was added at the concentration of 120µM and DMSO
(2% final) was used as solvent control. The plate was incubated
at 28◦C for 48 h under static condition. After 48 h, culture was
discarded and wells were washed with water. Biofilm appeared
in the form of rings on the walls of the wells. Crystal Violet
(CV) was added to each well to stain the biofilm for 15min at
room temperature. After staining, wells were washed with water
to remove excess of CV and 70% ethanol was added to dissolve
the stain. The dissolved stain was taken in a fresh plate tomeasure
the absorbance at 570 nm.
Biofilm formation in low magnesiummedium was carried out
in glass tubes. Overnight culture of bacterial strains, grown in
LB, was washed with NCE medium and diluted 1:20 into 500 µl
of NCE medium supplemented with 10µM Mg2+ in the glass
tube. MgtR peptide was added at the concentration of 120µM
and DMSO was used as solvent control. The glass tubes were
incubated at 30◦C for 24 h under static condition. Staining of
biofilm ring with CV (0.1%) was quantified as described above.
To measure bacterial viability, aliquots of bacterial culture and
PBS-washed ring were diluted in PBS for CFU counting.
Preparation of Lysates From Bacterial
Cultures Treated With Synthetic Peptide
Overnight culture of P. aeruginosa grown in LB medium was
diluted 1:5 in LB and grown until OD600nm of 0.8 to 1.
Bacteria were washed in NCE medium (Blanc-Potard and
Groisman, 1997) without magnesium and were resuspended
in the same medium supplemented with 10µM Mg2+ and
synthetic peptides (at the indicated concentration) or DMSO
as control. Bacteria were harvested after 4–5 h of incubation at
37◦C. To prepare whole-cell extracts, cultures were normalized
to OD600nm, centrifuged, re-suspended in Laemmli buffer and
lysed by heating at 95◦C for 10min before performing Western
Blot assay.
Preparation of Anti-PA4635 Antibodies
A DNA fragment encoding the C-terminal domain of
MgtC (PA4635) was amplified using primers indicated
in Supplemental Table 1 and cloned into pQE30 vector
(Qiagen). Recombinant plasmid was introduced intoM15/pRep4
E. coli strain to express and purify the His-tagged recombinant
protein as described (Alix and Blanc-Potard, 2008). Polyclonal
antibodies were produced upon immunization of rabbit with the
PA4635 C-ter domain (Eurogentec).
Western Blot Analysis
Total bacterial lysates were electrophoresed on 12.5% SDS-
PAGE gels and transferred onto nitrocellulose membrane
(Invitrogen) for immunoblotting. Rabbit anti-PA4635 were
used at 1:2,000 dilution and Mouse anti-EF-Tu antibody (Ball
et al., 2016) was used at 1:20,000 dilution. Anti-rabbit or anti-
mouse antibodies (dilution 1:30,000) labeled with fluorescent dye
DyLight 800 (Thermoscientific) were used for the detection of
PA4635 and EF-Tu using LICOR Odyssey Fc Imaging System
(excitation 783 nm and emission 797 nm) to quantify the amount
of proteins.
RESULTS AND DISCUSSION
Contribution of EPS to the
Intramacrophage Survival Defect and
Biofilm Phenotype of P. aeruginosa
In vitro, P. aeruginosa PAO1 produces mainly Psl and Pel,
whereas alginate synthesis is negatively regulated in this non-
mucoidal strain by the anti-sigma factor of MucA (Schurr et al.,
1996; Franklin et al., 2011). However, the expression of EPS genes
has not been measured when PAO1 resides in macrophages. To
address a putative link between the intramacrophage survival
defect of P. aeruginosa mgtC mutant and EPS production, we
first analyzed the level of expression of candidate individual
EPS genes, pelA, pslA, and algE, in P. aeruginosa mgtC mutant
and wild-type strain residing in J774 macrophages. Each of
these genes is a part of the respective operons required for
synthesis of Pel, Psl and alginate polysaccharides (Franklin et al.,
2011). A significant increased expression of pslA and, to a
lesser extent, algE was detected in mgtC mutant as compared
to wild-type strain, whereas pelA expression remained unaltered
(Figure 1), suggesting a higher production of Psl and alginate
inside macrophages bymgtCmutant.
A Salmonella mgtC mutant has been reported to
exhibit increased production of cellulose, another type
of exopolysaccharide, inside macrophages, and the
intramacrophage replication defect of the Salmonella mgtC
mutant could be reversed by an additional mutation in the bcsA
gene that prevented cellulose synthesis (Pontes et al., 2015).
To investigate whether the intramacrophage survival defect of
the P. aeruginosa mgtC mutant could be related to increased
Psl or alginate production within macrophages, we constructed
mgtC pslD, and mgtC alg8 double mutants (see Materials and
Methods), because pslD and alg8 are essential for Psl and alginate
synthesis, respectively (Remminghorst and Rehm, 2006; Byrd
et al., 2009). No rescue in the survival inside macrophages was
observed for mgtC mutant in the presence of psl or alg mutation
(Figure 2A), indicating that the survival defect of P. aeruginosa
mgtC mutant is not linked to increased production of Psl or
alginate. Thus, despite the observed increased expression of psl
and alg genes, EPS did not contribute to the intramacrophage
phenotype of P. aeruginosa mgtC mutant. These findings differ
from the results obtained in S. Typhimurium with mgtC bcsA
double mutant (Pontes et al., 2015). In contrast to P. aeruginosa,
Salmonella actively replicates inside macrophages, and increased
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FIGURE 1 | Expression of EPS genes in P. aeruginosa strains residing in J774 macrophages. Expression of EPS genes in strains PAO1 wild-type (WT) and 1mgtC
mutant infecting J774 macrophages. RNA was extracted from bacteria isolated from infected macrophages 1 h after phagocytosis. The level of pslA, algE, and pelA
transcripts relative to those of the house-keeping gene rpoD was measured by qRT-PCR and plotted on the Y-axis. Error bars correspond to standard errors from at
least three independent experiments. The asterisks indicate P-values (Student’s t-test *P < 0.05, **P < 0.01), showing statistical significance with respect to WT.
FIGURE 2 | Phenotypes of mgtC pslD and mgtC alg8 double mutants. (A) Behavior of mgtC pslD and mgtC alg8 double mutant within J774 macrophages. Survival
of P. aeruginosa PAO1 WT, 1mgtC, 1mgtC 1pslD and 1mgtC 1alg8 strains was assessed upon phagocytosis by J774 macrophages. Results are expressed as
percentage of surviving bacteria 2 h after phagocytosis compared to the number of bacteria 20min after phagocytosis and are normalized to 100% for WT strain.
Error bars correspond to standard errors from four independent experiments. The asterisks indicate P-values (One-way ANOVA followed by a Bonferroni post-test.
***P < 0.001). (B) Quantification of bacterial adherence to glass tubes to infer the ability of strains to form biofilm. P. aeruginosa strains PAO1 WT, 1mgtC, 1mgtC
1pslD, and 1mgtC 1alg8 were grown at 30◦C for 24 h in NCE medium with 10µM MgSO4. The biofilm quantification is visualized by CV ring on the glass tubes and
CV is quantified at 570 nm. Error bars correspond to standard errors (+SE) from three independent experiments and the asterisks indicate P-values (One-way ANOVA
followed by a Bonferroni post-test, *P < 0.05, **P < 0.01, ***P < 0.001). (C) Growth curve of P. aeruginosa strains PAO1, 1mgtC, 1mgtC 1pslD and 1mgtC 1alg8
in NCE medium supplemented with 10µM (left panel) or 1mM (right panel) MgSO4. The results are expressed as the mean ± SD of three independent experiments.
cellulose production may somehow contribute to the replication
defect of Salmonella mgtCmutant within macrophages.
As reported earlier, the formation of biofilm was found to be
significantly increased for mgtC mutant comparatively to wild-
type strain in low magnesium medium (Figure 2B), a condition
that induces expression of mgtC gene (Belon et al., 2015). The
formation of biofilm of mgtC alg8 double mutant was identical
to the one of mgtC mutant, whereas the biofilm formation was
significantly reduced inmgtC pslD double mutant comparatively
to mgtC mutant (Figure 2B). This finding correlated with
the growth curves of the different strains in low magnesium
(10µM) medium (Figure 2C), where growth of mgtC mutant
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 5 April 2019 | Volume 9 | Article 84
Moussouni et al. Antivirulence Strategy Targeting P. aeruginosa MgtC
was impaired in low magnesium medium comparatively to wild-
type strain, and presence of a pslD mutation, but not an alg8
mutation, improved the growth of themgtCmutant (Figure 2C).
All strains grew similarly in medium supplemented with 1mM
magnesium (Figure 2C).
Non-mucoid P. aeruginosa strains, as PAO1, utilize primarily
the Psl and Pel polysaccharides for biofilm formation, whereas
alginate is the predominant extracellular polysaccharide of the
matrix of mucoid strains (Wozniak et al., 2003). Our results
indicate that Psl polysaccharide, which is known to be more
important than Pel polysaccharide in P. aeruginosa PAO1 biofilm
formation (Yang et al., 2011), contributes to the increased biofilm
formation and impaired growth of mgtC mutant in magnesium
deprived medium. The growth defect of the mgtC mutant in low
magnesium medium is associated with the formation of bacterial
aggregates both on the tube (at the air-liquid level) and within the
culture, thus reminiscent of biofilm initiation. This is consistent
with the contribution of Psl, which is known to be produced
during planktonic growth, mediating attachment to surfaces and
contributing to microcolony formation (Ghafoor et al., 2011).
Effect of Synthetic MgtR Peptide on
Macrophage Survival of Wild-Type
P. aeruginosa PAO1 Strain
P. aeruginosa naturally lacks mgtR gene, but ectopic expression
of Salmonella mgtR in P. aeruginosa reduced intramacrophage
survival, thus mimicking the phenotype reported for mgtC
deletion mutant (Belon et al., 2015). To investigate the effect
of exogenous addition of peptide, we added synthetic MgtR
peptide to P. aeruginosa. The MgtR peptide, which harbors
73% of hydrophobic residues, is predicted to be organized
in a single transmembrane helix (Figure 3A), which has
been confirmed by an NMR structural analysis (Jean-Francois
et al., 2014). MgtR was chemically synthesized using optimized
protocol for hydrophobic peptides (see Materials and Methods)
and the alpha-helical fold was verified by circular dichroism
(Supplemental Figure S1). To address the effect of synthetic
peptide on the ability of wild-type P. aeruginosa PAO1 strain
to survive inside macrophages, bacteria were treated for 15min,
before phagocytosis, with 120µM of peptide solubilized in
DMSO. Bacteria pretreated with DMSO were used as control.
Phagocytosis by J774 macrophages was allowed for 30min
before removing extracellular bacteria with PBS washes and
gentamicin treatment. The bacterial survival was then monitored
for 2 h after phagocytosis. Bacteria treated with MgtR peptide
had a significantly lower intramacrophage survival than bacteria
treated with DMSO, which is in the same range as the one
observed for mgtC mutant (Figure 3B). Interestingly, addition
of MgtR peptide did not lower the survival of mgtC mutant,
suggesting that the presence of MgtC plays a role in the biological
activity of the synthetic peptide toward macrophage infection
(Figure 3B). In the condition used, the MgtR peptide is not
cytotoxic to J774 cells as shown by quantification of LDH
release (Supplemental Figure S2). We designed and synthesized
a scrambled peptide that contained the amino-acids of MgtR
in a scrambled order, thus retaining the hydrophobicity, but
lacking a predicted membrane helix, as shown using the
TMHMM program (Figure 3A). As expected, the scrambled
peptide exhibited a circular dichroism spectra that differs from
the one of MgtR, indicative of a loss of the alpha-helix structure
(Supplemental Figure S1). Importantly, no significant decrease
of intramacrophage survival was observed with this scrambled
peptide used at 120µM (Figure 3C), suggesting that the
biological effect of the synthetic MgtR peptide is somehow linked
to sequence specificity and not only to overall hydrophobicity.
Intramacrophage survival assay with wild-type P. aeruginosa
strain showed that addition of exogenous MgtR peptide mimics
the phenotype of mgtC mutant as well as the effect previously
reported upon endogenous expression of the peptide in PAO1,
supporting a biological activity exhibited by this synthetic
peptide. Moreover, this biological activity is linked to the
presence of MgtC.
Effect of Synthetic MgtR Peptide on MgtC
Protein Level, Bacterial Growth and Biofilm
Formation With P. aeruginosaWild-Type
PAO1
To address the mechanism of action of MgtR peptide, we have
conducted additional experiments upon addition of the peptide
to P. aeruginosa bacterial cultures. Because endogenous MgtR
peptide drives MgtC to degradation in S. Typhimurium (Alix
and Blanc-Potard, 2008), we investigated the effect of synthetic
MgtR peptide on the level of P. aeruginosa MgtC protein.
Total lysates were prepared from bacteria grown in magnesium
deprived medium, a condition that induces expression of mgtC
gene (Belon et al., 2015), treated or not with peptide. Western
blotting was carried out with anti-MgtC antibodies (see Materials
and Methods). Hybridization with antibodies against EF-Tu
were used as control (Ball et al., 2016). Addition of peptide to
bacterial culture caused a decrease in the level of MgtC in a
dose responsive manner, with the highest reduction at a final
concentration of 120µM, whereas the level of EF-Tu control
protein remained unchanged (Figure 4A). In contrast to MgtR,
the scrambled peptide had only a minor effect on the level of
MgtC protein (Figure 4B).
We also monitored the effect of MgtR on bacterial viability
and growth, to determine whether MgtR behaves as the known
antimicrobial peptides. The effect of MgtR on the level of MgtC
protein is not related to an effect on bacterial viability in NCE
medium (Figure 4C), which is consistent with the constant level
of EF-Tu control protein. We have also shown that addition of
MgtR peptide had no effect on bacterial growth in LB medium
(Figure 4D), indicating that synthetic MgtR does not have a
classical antibacterial effect.
We further investigated the effect of MgtR on the ability of
P. aeruginosa to form biofilm. We first tested biofilm formation
of PAO1 strain grown in LB medium. Addition of MgtR did
not change significantly the ability of PAO1 to form biofilm
(Figure 5A). Biofilm formation was also tested in magnesium
deprived medium. As shown before, increased biofilm formation
is seen with the mgtC mutant strain comparatively to wild-
type strain, but no significant increase is detected upon
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FIGURE 3 | Effect of synthetic MgtR peptide on P. aeruginosa intramacrophage survival. (A) Sequence and transmembrane helix prediction for MgtR and scrambled
MgtR peptides, using TMHMM program (http://www.cbs.dtu.dk/services/TMHMM/). (B) To test the effect of synthetic MgtR peptide on P. aeruginosa
intramacrophage survival, PAO1 WT strain was treated with 120µM of MgtR peptide or DMSO for 15min before phagocytosis. A 1mgtC mutant treated with DMSO
or MgtR peptide (120µM) is used as control. Error bars correspond to standard errors (+SE) from at least four experiments. Statistical analysis was performed with
one-way ANOVA followed by a Bonferroni post-test, ***P < 0.001. (C) To test the effect of synthetic scrambled MgtR peptide on P. aeruginosa intramacrophage
survival, PAO1 WT strain was treated with 120µM of MgtR scrambled peptide or DMSO for 15min before phagocytosis. Error bar corresponds to standard errors
(+SE) from at least three experiments. Statistical analysis was performed with one-way ANOVA followed by a Bonferroni post-test.
addition of MgtR peptide to PAO1 strain in the condition
tested (Figure 5B). Moreover, bacterial viability, in the ring
or in the planktonic fraction, is not significantly modified in
PAO1 treated with MgtR comparatively to non-treated bacteria
(Supplemental Figure S3).
Cumulatively, we have shown that, in addition to reduce
intramacrophage survival, the biological action of syntheticMgtR
is associated with a decreased level of MgtC protein, without
any effect on growth rate. Despite the decreased level of MgtC,
the exogenous peptide had no effect on biofilm formation.
A similar finding was found upon endogenous production of
MgtR (Supplemental Figure S4). These results may indicate
that the effect of MgtR is delayed upon long term phenotype,
such as biofilm. We cannot exclude a deterioration of the
peptide with time. In addition, or alternatively, MgtR may
also act by preventing protein-protein interaction relevant for
intramacrophage survival but not for biofilm formation.
CONCLUSION
Antivirulence strategies are being increasingly considered in
the age of antibiotic resistance (Dickey et al., 2017) and we
have previously proposed MgtC as a valuable target with a
potent inhibitory peptide, MgtR. The function of MgtC has been
mainly studied in S. Typhimurium, where it exhibits pleiotropic
roles, including inhibition of F1Fo ATP synthase (Lee et al.,
2013) and modulation of cellulose production (Pontes et al.,
2015). Our results provide a link between P. aeruginosa MgtC
and EPS production and show an implication of EPS, more
specifically Psl, for the increased biofilm formation of mgtC
mutant in magnesium deprived medium. However, EPS are not
involved in the intramacrophage behavior of P. aeruginosa mgtC
mutant, thus differing from the role reported for cellulose in the
intracellular pathogen S. Typhimurium.
Our previous results indicated that endogenous production
of MgtR lowered the intramacrophage survival of wild-type
P. aeruginosa PAO1 strain (Belon et al., 2015). Using for the
first time a synthetic MgtR peptide on PAO1 strain led to
a similar effect, associated with a decrease of MgtC protein
level, thus supporting the use of such peptide to target
the MgtC virulence factor. MgtR did however not increase
significantly biofilm formation, indicating an action towards
EPS-independent phenotype rather than EPS-related phenotype.
The lack of significant effect with a synthetic scrambled peptide
derived from MgtR suggested that biological activity of synthetic
MgtR peptide is somehow linked to sequence specificity and not
to overall hydrophobicity. Hydrophobic compounds as MgtR
remain difficult to handle and therefore improving peptide
solubility, while keeping efficiency, will be valuable. The interest
for peptides as new therapeutic molecules has recently increased
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FIGURE 4 | Effect of synthetic MgtR peptide on the level of MgtC protein and on P. aeruginosa growth rate. (A) Effect of MgtR peptide on MgtC level is evaluated on
total lysates of PAO1 WT bacteria incubated during 4 h with different concentrations of MgtR peptide in NCE medium supplemented with 10µM MgSO4. The
membranes were probed with the anti-MgtC and anti-EF-Tu antibodies, as loading control. A representive experiment out of three independent experiments is shown.
The quantified ratio PA4635/EF-Tu is 1, 0.95, 0.28, 0.01 for MgtR concentrations of 0, 40, 80, and 120µM, respectively. (B) Effect of a scrambled peptide derived
from MgtR on the level of MgtC protein. PAO1 WT bacteria were grown for 1.5 h in NCE medium supplemented with 10µM MgSO4 before addition of 120µM MgtR
or 120µM scrambled MgtR and were incubated further for 5 h before harvesting total lysates for blotting. A representative experiment out of three independent
experiments is shown. (C) Effect of MgtR peptide on bacterial viability in NCE medium. PAO1 WT strain was treated with 120µM MgtR and incubated in NCE medium
supplemented with 10µM MgSO4 for 24 h. At indicated time points, 10 µl of the culture was collected and diluted on LB agar plate to quantify CFUs. The results are
expressed as the mean ± SD of three independent experiments. (D) Effect of MgtR peptide (120µM) on the bacterial growth of PAO1 WT in LB medium. The results
are expressed as the mean ± SD of three independent experiments.
FIGURE 5 | Biofilm formation in the presence of synthetic MgtR peptide. (A) Quantification of bacterial adherence in LB medium. PAO1 WT strain was incubated with
120µM MgtR peptide or DMSO as control in LB and allowed to form biofilm at 28◦C for 48 h in 96 well plate. Biofilm was stained with crystal violet and absorbance
was measured at 570 nm. Statistical analysis was done on three independent experiments by one way ANOVA, where all samples were compared to DMSO using
Dunnet’s multiple comparison post-test, showing statistical significance with respect to DMSO control (ns > 0.05, non-significant). (B) Quantification of bacterial
adherence to glass tubes in magnesium deprived medium. Adherence assay was carried out with PAO1 WT and 1mgtC strains grown at 30◦C for 24 h in NCE
medium with 10µM MgSO4 supplemented or not with 120µM MgtR peptide. The ring on the glass tube is visualized by crystal violet staining and quantified by
measuring OD570. Error bars correspond to standard errors (+SE) from three independent experiments and the asterisks indicate P-values (One-way ANOVA followed
by a Bonferroni post-test, ***P < 0.001).
(Kruger, 2017), and peptide modulators of protein-protein
interaction in membranes are promising molecules (Stone and
Deber, 2017). The present work thus identifies a synthetic
hydrophobic peptide, issued from a natural bacterial peptide,
which could limit bacterial pathogenesis and which differs from
classical anti-microbial peptides (Mahlapuu et al., 2016) because
of lack of effect on bacterial viability.
Further work will be required to decipher the mechanism of
action of synthetic MgtR peptide. Our present results show that
peptide addition is associated with a decreased level of MgtC
protein but, as suggested earlier, MgtR may also prevent protein-
protein interaction involving the MgtC protein (Belon et al.,
2016). The lack of effect of MgtR peptide in the context of a
mgtC mutant suggests that its biological effect is mainly related
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to the presence of MgtC protein. Despite this finding and the
absence of noticeable growth defect upon addition of MgtR, it
would be of interest to test in a more general way the impact of
syntheticMgtR onmembrane fluidity and integrity. Interestingly,
MgtR does not appear to modulate biofilm formation, suggesting
that MgtR may act more specifically during acute infection
than chronic infection. Given the proof of concept provided
by our results on infected cells with PAO1 strain, further
work will be required to test the efficiency of such peptide
on P. aeruginosa clinical isolates and in an animal model
of infection.
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